23 Daily — According to gamesindustry.biz, game developer Remedy has reported a significant surge in its third-quarter revenue for 2026, driven by the launch of the new title Control Resonant on September 24. Revenue rose by 226% year-over-year, reaching €39.6 million, marking a new milestone for the company. CEO Jean-Charles Gaudechon described this as a "defining milestone for the company."
Control Resonant Triples Quarterly Revenue
Control Resonant, one of Remedy's highly anticipated titles, was digitally released on September 24, with a physical edition following on October 15 after the financial review period. Since launch, the game has sold over one million copies, becoming Remedy's fastest-selling title to date. Preorders and first-week sales of Resonant helped triple the company's Q3 revenue.
The United States accounted for nearly half of Resonant's PC and console sales. On the PC platform, Chinese-speaking regions and the UK ranked second and third respectively; on consoles, the UK, Canada, and Brazil were the second to fourth largest markets.
Expanding Player Base and Significant Potential Audience
Internal data from Remedy revealed that nearly half of Resonant players are new to the Control franchise, indicating successful outreach to new players. The company stated that the game has an outstanding wishlist of 2.4 million on digital platforms, demonstrating a substantial potential audience for future sales.
Additionally, the original Control game from 2019 also benefited from Resonant's strong launch, with sales exceeding both the comparison period and the first two quarters of the current year.
Other Financials and Cost Overview
Remedy noted that the Alan Wake franchise experienced a quieter quarter, but capitalised development costs for Alan Wake 2 are now fully depreciated. Game sales and royalties formed the majority of Q3 revenue, totaling €35 million, up from €6 million in the same period last year. Development fees from the Max Payne 1 and 2 remakes and final fees from Resonant's development agreement with Annapurna amounted to €4.3 million.
Since Remedy is now self-publishing its titles, it directly incurs royalty expenses and platform fees, including Annapurna's revenue share from Resonant. The company stated these royalty expenses will decrease once initial investments are recouped. Development costs for Resonant began depreciating after launch, and marketing expenses peaked around that time.
Editor's take: Revenue surge lays groundwork for long-term growth
Remedy CEO Jean-Charles Gaudechon emphasized the company's current priority is to put Control Resonant in the hands of more players. The game's excellent player reviews, penetration across target markets, and large wishlist base form a solid foundation for its long-term sales potential.
Remedy plans to invest with discipline, focusing marketing efforts on initiatives with clear returns to ensure effective use of resources. The sequel has established Control as a true franchise, and other projects in Remedy's pipeline continue progressing. Sales for the remainder of the year will ultimately shape the financial results for 2026, with Resonant providing a strong platform for growth.